• 点赞
  • 2
  • 收藏

Bellicum Announces $25.0 Million Underwritten Offering Priced At-The-Market

GlobeNewswire2020-10-30

HOUSTON, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced the pricing of...

网页链接

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论2

 
 
 
 

热议股票

 
 
 
 
 

7x24